SoloFire vs. Letter AI
A side-by-side comparison based on G2 review data.
| Metric | SoloFire | Letter AI |
|---|---|---|
| Overall rating | 4.4 | 4.9 |
| Review count | 26 | 83 |
| Ease of use | 9.3 | 9.4 |
| Ease of setup | 9.1 | 9.3 |
| Quality of support | 9.0 | 9.9 |
| Meets requirements | 8.8 | 9.5 |
| NPS | 64 | 96.385542 |
| Small Business | 42.3% | 2.7% |
| Mid-Market | 42.3% | 67.1% |
| Enterprise | 15.4% | 30.1% |
| Total page views | 81 | 2,310 |
| Total LLM citations | 9 | 6,376 |
SoloFire
SoloFire is a sales enablement platform built specifically for field sales teams in medical device and life sciences. Founded in 2014, SoloFire has spent over a decade solving the unique challenges that come with selling complex products in clinical, surgical, and healthcare environments — where reps need to be prepared, content needs to be accessible, and every buyer interaction needs to count. Today, SoloFire serves more than 35,000 field reps across leading medical device and life sciences brands, with over 8 million buyer engagements delivered through the platform.
Letter AI
Letter AI is a unified revenue enablement platform built natively with AI. All in one easy-to-use platform Letter not only is a Content Management System and Learning Management System, our AI workflows and generative AI capabilities create content and AI-powered training and role play in minutes. Being AI-native means our Deal Pursuit capabilities, like AI Sales Rooms and end-to-end RFP automation, are deeply connected to your enablement capabilities. Letter AI empowers your enablement teams to supercharge the revenue journey.
- Ease of Use
- Customer Support
- Helpful
- Useful
- Time-saving
- Intuitive